We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
IPCALAB.NSE

Price
1465.90
Stock movement down
-6.00 (-0.41%)
Company name
IPCA Laboratories Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
371.91B
Ent value
403.74B
Price/Sales
3.97
Price/Book
4.19
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
44.71
Forward P/E
32.05
PEG
-
EPS growth
3.93%
1 year return
-6.06%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

IPCALAB.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E44.71
Price to OCF17.70
Price to FCF43.03
Price to EBITDA18.68
EV to EBITDA20.28

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales3.97
Price to Book4.19
EV to Sales4.31

FINANCIALS

Per share

Per share data
Current share count253.70M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)45.73

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash2.13B
Net receivables21.28B
Total current assets62.52B
Goodwill828.10M
Intangible assets1.20B
Property, plant and equipment49.45B
Total assets122.63B
Accounts payable8.22B
Short/Current long term debt12.79B
Total current liabilities25.37B
Total liabilities33.97B
Shareholder's equity88.66B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Stock price data
Open1478.30
Daily high1487.90
Daily low1458.90
Daily Volume99K
All-time high1744.05
1y analyst estimate1551.82
Beta0.16
EPS (TTM)-
Dividend per share0.00
Ex-div date5 Aug 2025
Next earnings date12 Feb 2026

Downside potential

Downside potential data
IPCALAB.NSES&P500
Current price drop from All-time high-15.95%-1.08%
Highest price drop-27.26%-19.00%
Date of highest drop24 Oct 20258 Apr 2025
Avg drop from high-16.76%-2.64%
Avg time to new high59 days6 days
Max time to new high238 days89 days
COMPANY DETAILS
IPCALAB.NSE (IPCA Laboratories Limited) company logo
Marketcap
371.91B
Marketcap category
Large-cap
Description
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Employees
16778
Website
https://www.ipca.com
Investor relations
-
SEC filings
IPCALAB.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesFeatured ArticlesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved